Skip to content
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Occupational Medicine · Occupational Asthma

Environmental and Occupational Asthma

At a Glance

Occupational asthma is caused by workplace exposures, while work-exacerbated asthma is pre-existing asthma made worse at work. Objective breathing tests during and away from work help confirm the link, and early exposure control or removal improves the chance of recovery.

Asthma is often thought of as a childhood illness, but for many adults, the air they breathe at work or in their daily environment is the primary driver of their symptoms. When your surroundings cause or worsen your asthma, it is categorized as work-related asthma or environmental asthma [1]. Understanding whether your workplace is the source of your breathing difficulties is critical because the management strategies—such as changing your work tasks or improving ventilation—differ significantly from standard asthma care [2].

Defining Workplace and Environmental Asthma

Medical experts divide asthma related to the workplace into two main categories: occupational asthma, which is caused directly by something at work, and work-exacerbated asthma, which is pre-existing asthma that gets worse due to workplace conditions [1][2].

Sensitizer-Induced Occupational Asthma

This is the most common form of occupational asthma. It occurs when you become “sensitized” or allergic to a specific substance at work [3].

  • The Latency Period: You do not usually get symptoms the first time you are exposed. Instead, there is a latency period—weeks, months, or even years of exposure—during which your immune system gradually develops a sensitivity to the trigger [3]. Once sensitized, even tiny amounts of the substance can trigger a severe attack [4].
  • Common Triggers: These are often divided by their size. High-molecular-weight triggers are usually proteins like flour, grain dust, animal dander, or latex [5]. Low-molecular-weight triggers are chemicals like isocyanates (found in spray paints and foams), wood dusts, or certain metals [6][7].

Irritant-Induced Occupational Asthma

Unlike the allergic form, this type does not require a sensitization period. It happens when high levels of irritating fumes, gases, or dusts physically damage the airways [8].

  • Reactive Airways Dysfunction Syndrome (RADS): This is a specific subtype where asthma-like symptoms begin within 24 hours of a single, very high-level exposure to an irritant, such as a chemical spill or smoke [9][10].
  • Chronic Irritant Asthma: Recent research shows that irritant-induced asthma can also develop more slowly after repeated exposure to lower levels of irritants, such as cleaning products or disinfectants [11][12].

Work-Exacerbated Asthma

In this case, you already have asthma (even if it was mild or quiet), but your workplace makes it worse [1]. Triggers like cold air, physical exertion, dust, or strong odors in the office or factory floor cause frequent flare-ups [13]. While work didn’t cause the asthma, it prevents it from being well-controlled [14].

The Biology: Overlapping Inflammatory Pathways

To treat your asthma effectively, doctors look at the underlying biological “flavor” of the inflammation in your lungs. These phenotypes overlap and test results must be interpreted carefully by your doctor.

Type 2 Inflammation (Allergic/Eosinophilic)

This pathway involves an overactive immune response where cells called eosinophils (a type of white blood cell) flood the airways [15].

  • IgE-Mediated: In many cases, your body produces IgE (allergic) antibodies against a workplace trigger [16].
  • The “Innate” Route: Interestingly, you can have Type 2 inflammation without a traditional allergy. Some triggers damage the airway lining, which then releases “alarm” signals that recruit eosinophils directly, even if an allergy test comes back negative [16][17].

Non-Type 2 Inflammation (Neutrophilic)

This pathway is more common in irritant-induced asthma and is often linked to air pollution or tobacco smoke, though irritant asthma can also have mixed or eosinophilic patterns [17][18]. Instead of eosinophils, the lungs may be crowded with neutrophils, cells typically associated with fighting infections [19]. Non-Type 2 asthma phenotypes can sometimes be harder to treat because they may not respond as well to standard inhaled steroids, though inhaled steroids remain important [20].

Environmental Triggers Outside of Work

Beyond the workplace, your broader environment plays a significant role in lung health.

  • Air Pollution: Particulate matter (PM2.5) and gases like nitrogen dioxide can trigger immediate asthma attacks and contribute to long-term lung inflammation [21][22].
  • Residential Exposure: Common household triggers include mold, dust mites, and pet dander. These typically drive Type 2 (allergic) inflammation [23][24].

What the Research Says About Your Future

If you are diagnosed with occupational asthma, the evidence suggests that early evaluation and exposure control improve the chances of controlling the condition [25].

  • Recovery: Many people see significant improvement or even remission if they stop breathing the trigger early on [8]. However, if exposure continues for a long time, the airway damage can become permanent [26].
  • The Trade-off: Research also highlights a difficult reality: while leaving a job may help your lungs, it can lead to financial strain or unemployment [25]. For confirmed sensitizer-induced occupational asthma, complete avoidance generally provides the best prognosis.
  • Seek Help: You should not navigate this alone. A patient should not resign or make employment decisions without support, but also should not interpret Personal Protective Equipment (PPE) as making a sensitizing exposure safe. An occupational-medicine or industrial-hygiene professional can help coordinate with your employer regarding ventilation, safety programs, and workers’ compensation [1].

Current consensus guidelines emphasize that a diagnosis cannot be made by symptoms alone [2]. You will likely need objective tests, such as breathing tests performed both at and away from work, to prove the connection and ensure you receive the right protections [12][27].

Common questions in this guide

What is the difference between occupational asthma and work-exacerbated asthma?
Occupational asthma develops because a workplace substance or condition causes asthma. Work-exacerbated asthma existed before but becomes worse at work. The distinction helps determine whether changing tasks, improving ventilation, or avoiding the exposure is needed.
How is work-related asthma diagnosed?
Symptoms alone cannot prove that work caused or worsened asthma. A clinician may use breathing tests, such as serial peak-flow readings, during work periods and away from work; other tests, including a methacholine challenge, may also be considered. Keeping a record of symptoms, work duties, and time away can help with the evaluation.
What substances commonly cause occupational asthma?
Common sensitizers include flour or grain dust, animal dander, latex, isocyanates in some paints and foams, wood dust, and certain metals. Irritant fumes, gases, dusts, cleaning products, and disinfectants can also trigger asthma without a typical allergy.
Can a single chemical spill cause asthma?
Yes. Reactive airways dysfunction syndrome, or RADS, is an asthma-like illness that can begin within 24 hours after one very high-level exposure to an irritant such as a chemical spill or heavy smoke. Asthma can also develop more gradually after repeated lower-level irritant exposures.
Can air pollution or household exposures worsen asthma?
Yes. Particulate air pollution and nitrogen dioxide can trigger attacks and contribute to ongoing airway inflammation. At home, mold, dust mites, and pet dander commonly worsen allergic asthma.
What should I do if my asthma improves when I am away from work?
Tell your healthcare clinician and ask whether you need evaluation for work-related asthma, often with occupational medicine involvement. Do not quit your job or assume personal protective equipment makes a sensitizing exposure safe without professional guidance; ventilation, task changes, exposure removal, and workplace support may be considered.
Can occupational asthma get better after exposure is reduced?
Early identification and stopping or reducing exposure can improve control and sometimes lead to remission. Long-term exposure can cause persistent airway damage, so work-related symptoms should be evaluated promptly with help from clinicians and occupational health professionals.

Get notified when new evidence is published on environmental induced asthma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (27)
  1. 1

    Occupational asthma and work-exacerbated asthma.

    Friedman-Jimenez G, Harrison D, Luo H

    Seminars in respiratory and critical care medicine 2015; (36(3)):388-407 doi:10.1055/s-0035-1550157.

    PMID: 26024347
  2. 2

    Work-related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia.

    Hoy R, Burdon J, Chen L, et al.

    Respirology (Carlton, Vic.) 2020; (25(11)):1183-1192 doi:10.1111/resp.13951.

    PMID: 33020986
  3. 3

    Progress in Occupational Asthma.

    Tiotiu AI, Novakova S, Labor M, et al.

    International journal of environmental research and public health 2020; (17(12)) doi:10.3390/ijerph17124553.

    PMID: 32599814
  4. 4

    An official American Thoracic Society Workshop Report: presentations and discussion of the fifth Jack Pepys Workshop on Asthma in the Workplace. Comparisons between asthma in the workplace and non-work-related asthma.

    Malo JL, Tarlo SM, Sastre J, et al.

    Annals of the American Thoracic Society 2015; (12(7)):S99-S110 doi:10.1513/AnnalsATS.201505-281ST.

    PMID: 26203621
  5. 5

    Occupational Respiratory Allergy: Risk Factors, Diagnosis, and Management.

    Raulf M

    Handbook of experimental pharmacology 2022; (268()):213-225 doi:10.1007/164_2021_472.

    PMID: 34031758
  6. 6

    Occupational asthma and rhinitis: Do we think about it as soon as possible?

    Klusáčková P, Lebedová J

    Casopis lekaru ceskych 2018; (157(8)):406-410.

    PMID: 30754977
  7. 7

    Recent developments in occupational asthma.

    Blouin C, Lemière C

    Current opinion in pulmonary medicine 2024; (30(3)):281-286 doi:10.1097/MCP.0000000000001062.

    PMID: 38415698
  8. 8

    Occupational asthma.

    Cormier M, Lemière C

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2020; (24(1)):8-21 doi:10.5588/ijtld.19.0301.

    PMID: 32005302
  9. 9

    Update on the Management of Occupational Asthma and Work-Exacerbated Asthma.

    Lau A, Tarlo SM

    Allergy, asthma & immunology research 2019; (11(2)):188-200 doi:10.4168/aair.2019.11.2.188.

    PMID: 30661311
  10. 10

    Nebulized Lidocaine as an Alternative Therapy for Reactive Airway Dysfunction Syndrome.

    Özyiğit LP, Erer A, Okumuş G, et al.

    Turkish thoracic journal 2016; (17(2)):82-83 doi:10.5578/ttj.17.2.017.

    PMID: 29404130
  11. 11

    Irritant-Induced Asthma.

    Lemiere C, Lavoie G, Doyen V, Vandenplas O

    The journal of allergy and clinical immunology. In practice 2022; (10(11)):2799-2806 doi:10.1016/j.jaip.2022.06.045.

    PMID: 35820617
  12. 12

    Update on irritant-induced occupational asthma.

    Ronsmans S, Le Moual N, Dumas O

    Current opinion in allergy and clinical immunology 2023; (23(2)):63-69 doi:10.1097/ACI.0000000000000884.

    PMID: 36729951
  13. 13

    Do chronic workplace irritant exposures cause asthma?

    Dumas O, Le Moual N

    Current opinion in allergy and clinical immunology 2016; (16(2)):75-85 doi:10.1097/ACI.0000000000000247.

    PMID: 26914673
  14. 14

    Work-related asthma.

    Roio LCD, Mizutani RF, Pinto RC, et al.

    Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 2021; (47(4)):e20200577 doi:10.36416/1806-3756/e20200577.

    PMID: 34406224
  15. 15

    T-helper cells and their cytokines in pathogenesis and treatment of asthma.

    Ji T, Li H

    Frontiers in immunology 2023; (14()):1149203 doi:10.3389/fimmu.2023.1149203.

    PMID: 37377958
  16. 16

    Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.

    van Rijt L, von Richthofen H, van Ree R

    Seminars in immunopathology 2016; (38(4)):483-96 doi:10.1007/s00281-016-0556-2.

    PMID: 26965110
  17. 17

    Immunologic mechanisms in asthma.

    Boonpiyathad T, Sözener ZC, Satitsuksanoa P, Akdis CA

    Seminars in immunology 2019; (46()):101333 doi:10.1016/j.smim.2019.101333.

    PMID: 31703832
  18. 18

    Mechanisms of non-type 2 asthma.

    Hudey SN, Ledford DK, Cardet JC

    Current opinion in immunology 2020; (66()):123-128 doi:10.1016/j.coi.2020.10.002.

    PMID: 33160187
  19. 19

    Treatment options in type-2 low asthma.

    Hinks TSC, Levine SJ, Brusselle GG

    The European respiratory journal 2021; (57(1)) doi:10.1183/13993003.00528-2020.

    PMID: 32586877
  20. 20

    TH17 cells and corticosteroid insensitivity in severe asthma.

    Xie Y, Abel PW, Casale TB, Tu Y

    The Journal of allergy and clinical immunology 2022; (149(2)):467-479 doi:10.1016/j.jaci.2021.12.769.

    PMID: 34953791
  21. 21

    Environmental triggers and avoidance in the management of asthma.

    Gautier C, Charpin D

    Journal of asthma and allergy 2017; (10()):47-56 doi:10.2147/JAA.S121276.

    PMID: 28331347
  22. 22

    The Impact of Ambient Environmental and Occupational Pollution on Respiratory Diseases.

    Nishida C, Yatera K

    International journal of environmental research and public health 2022; (19(5)) doi:10.3390/ijerph19052788.

    PMID: 35270479
  23. 23

    Environmental Causes of Asthma.

    Cockcroft DW

    Seminars in respiratory and critical care medicine 2018; (39(1)):12-18 doi:10.1055/s-0037-1606219.

    PMID: 29427981
  24. 24

    Irritant occupational exposure and specific-IgE sensitisation in the EGEA cohort.

    Migueres N, Dumas O, Boudier A, et al.

    Occupational and environmental medicine 2026; (83(2)):100-106 doi:10.1136/oemed-2025-110266.

    PMID: 42045018
  25. 25

    Workplace interventions for treatment of occupational asthma.

    Henneberger PK, Patel JR, de Groene GJ, et al.

    The Cochrane database of systematic reviews 2019; (10()):CD006308 doi:10.1002/14651858.CD006308.pub4.

    PMID: 31593318
  26. 26

    Severe Occupational Asthma: Insights From a Multicenter European Cohort.

    Vandenplas O, Godet J, Hurdubaea L, et al.

    The journal of allergy and clinical immunology. In practice 2019; (7(7)):2309-2318.e4 doi:10.1016/j.jaip.2019.03.017.

    PMID: 30914232
  27. 27

    Assessment and Management of Occupational Asthma.

    Cullinan P, Vandenplas O, Bernstein D

    The journal of allergy and clinical immunology. In practice 2020; (8(10)):3264-3275 doi:10.1016/j.jaip.2020.06.031.

    PMID: 33161958

This page is for informational purposes only and does not constitute medical advice. An occupational-medicine or asthma specialist should help interpret your tests and guide workplace exposure decisions.